| 000 | 01450 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250514202010.0 | ||
| 264 | 0 | _c20041129 | |
| 008 | 200411s 0 0 eng d | ||
| 022 | _a0066-4804 | ||
| 024 | 7 |
_a10.1128/AAC.48.10.4016-4019.2004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShelburne, Samuel A | |
| 245 | 0 | 0 |
_aIn vitro killing of community-associated methicillin-resistant Staphylococcus aureus with drug combinations. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _cOct 2004 |
||
| 300 |
_a4016-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aCommunity-Acquired Infections _xmicrobiology |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aDrug Therapy, Combination _xpharmacology |
| 650 | 0 | 4 |
_aGentamicins _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aMethicillin Resistance |
| 650 | 0 | 4 |
_aRifampin _xpharmacology |
| 650 | 0 | 4 |
_aStaphylococcal Infections _xmicrobiology |
| 650 | 0 | 4 |
_aStaphylococcus aureus _xdrug effects |
| 650 | 0 | 4 |
_aVancomycin _xpharmacology |
| 700 | 1 | _aMusher, Daniel M | |
| 700 | 1 | _aHulten, Kristina | |
| 700 | 1 | _aCeasar, Heather | |
| 700 | 1 | _aLu, Michael Y | |
| 700 | 1 | _aBhaila, Imran | |
| 700 | 1 | _aHamill, Richard J | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 48 _gno. 10 _gp. 4016-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.48.10.4016-4019.2004 _zAvailable from publisher's website |
| 999 |
_c15081401 _d15081401 |
||